Department of Diagnostic and Interventional Radiology, Zagreb University Hospital Center, Zagreb, Croatia.
Department of Urology, Zagreb University Hospital Center, Zagreb, Croatia.
Acta Clin Croat. 2023 Jul;62(Suppl2):37-45. doi: 10.20471/acc.2023.62.s2.6.
Although the gold standard in the management of kidney tumors is surgical treatment, thermal ablation methods are a viable therapeutic option for patients with small (<4 cm) renal masses who are poor surgical candidates. The aim of this study was to compare the technical success, primary efficacy and complication rate of percutaneous radiofrequency and microwave ablation in the treatment of small renal masses. A retrospective analysis of consecutive patients with small renal masses treated with radiofrequency or microwave ablation between December 2017 and January 2022 was conducted. Response to the ablative therapy was assessed on contrast-enhanced computed tomography examination after 3 months. Ablations of 44 kidney lesions were performed in 43 patients. Sixteen lesions were treated with radiofrequency and 28 with microwave ablation. Both methods were associated with high technical success (100%). Primary efficacy rates of radiofrequency and microwave ablation were 81.3% and 89.3%, respectively. Ablation-related complications were noted only in the patients treated with microwave ablation (18.5%), all of them being low grade (Clavien-Dindo 1 and 2). Radiofrequency and microwave ablation exhibited comparable efficacy in the treatment of small renal masses. Microwave ablation was associated with a comparatively higher number of complications.
尽管手术治疗是肾脏肿瘤治疗的金标准,但对于不适合手术的小(<4cm)肾肿瘤患者,热消融方法是一种可行的治疗选择。本研究旨在比较经皮射频和微波消融治疗小肾肿瘤的技术成功率、主要疗效和并发症发生率。对 2017 年 12 月至 2022 年 1 月期间连续接受射频或微波消融治疗的小肾肿瘤患者进行回顾性分析。在 3 个月后的增强 CT 检查评估消融治疗的效果。对 43 例患者的 44 个肾脏病变进行消融治疗。16 个病变采用射频消融,28 个病变采用微波消融。两种方法的技术成功率均很高(100%)。射频和微波消融的主要疗效率分别为 81.3%和 89.3%。仅在接受微波消融治疗的患者中观察到与消融相关的并发症(18.5%),均为低级别(Clavien-Dindo 1 和 2 级)。射频和微波消融治疗小肾肿瘤的疗效相当。微波消融的并发症相对较多。